New Relic to Present at Upcoming Investor Conferences

SAN FRANCISCO--(BUSINESS WIRE)-- Digital Intelligence leader New Relic, Inc. (NYSE: NEWR), today announced the following upcoming investor conference presentations.

Chief Financial Officer Mark Sachleben will present at:

• J.P. Morgan 45th Annual Global Technology, Media, and Telecom Conference in Boston, MA on Monday, May 22, 2017 at 3:40 p.m. ET or 12:40 p.m. PT.

Mark Sachleben and VP, Strategic Finance & Investor Relations Jonathan Parker will present at:

• Cowen 45th Annual Technology, Media, and Telecom Conference in New York City on Thursday, June 1, 2017 at 8:45 a.m. ET or 5:45 a.m. PT.

Chief Product Officer Jim Gochee and Jonathan Parker will present at:

• Baird 2017 Consumer, Technology & Services Conference in New York City on Thursday, June 8, 2017 at 10:15 a.m. ET or 7:15 p.m. PT.

Live webcasts of the presentations will be accessible from the investor relations page of the New Relic website at http://ir.newrelic.com. Following the events, replays will be made available at the same location.

About New RelicNew Relic is a leading digital intelligence company, delivering full-stack visibility and analytics to more than 40% of the Fortune 100. The New Relic Digital Intelligence Platform provides actionable insights to drive digital business results. Companies of all sizes trust New Relic to monitor application and infrastructure performance so they can quickly resolve issues, and improve digital customer experiences. Learn more at newrelic.com.

New Relic is a registered trademark of New Relic, Inc.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170517005265/en/

New Relic, Inc.
Investor Relations Contact:
Jonathan Parker, 503-336-9280
[email protected]
or
Media Contact:
Andrew Schmitt, 415-869-7109
[email protected]

Source: New Relic Corporate Communications

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Savers Value Village closes 23M share secondary offering
• Zentalis Pharmaceuticals Announces Pricing of Underwritten Public Offering
• Last Chance for Animals Condemns York University for Ignoring Public Outcry and Continuing to Defend Cruel Primate Research Program Despite Investigation Documenting Suffering of Nine Macaques